Legal Library: Cases and Proceedings

RentGrow, a provider of consumer reports for tenant screening, will be required to pay $2.25 million to settle Federal Trade Commission allegations that the company violated the Fair Credit Reporting Act (FCRA), including by failing to use reasonable procedures to ensure the accuracy of its reports, and the FTC Act.

The FTC announced a settlement Celsius Network that will permanently ban it from handling consumers’ assets and charged three former executives with tricking consumers into transferring cryptocurrency onto the platform by falsely promising that deposits would be safe and always available.

On July 8, 2026, the FTC, along with five states, secured an important settlement in an antitrust lawsuit against farm equipment manufacturer Deere & Company that will ensure farmers can enjoy the right to repair their own John Deere tractors and farm equipment.

The Federal Trade Commission, along with the New York Attorney General, are taking action against gig economy company Handy Technologies for making a broad array of deceptive claims about how much money workers on its platform could earn.

The complaint charges that Handy, which currently does business as Angi Services, has peppered its advertisements with earnings claims that don’t reflect the reality for the overwhelming majority of workers on the platform. The complaint also charges that Handy has failed to clearly disclose fees and fines that have led to millions of dollars being withheld from workers.

Under the terms of a proposed settlement order, Handy would be required to turn over $2.95 million to be used to provide refunds to harmed workers, and make substantial changes to ensure that workers give clear consent to any fees charged by the company and that the company gives workers clear direction about how to avoid fines.

Publishing.com LLC and its two principals will pay $1.5 million and be required to substantiate earnings claims in the future to settle Federal Trade Commission charges that the company and its operators misled consumers about how much money they were likely to earn using their products.

The companies that operate the Hopper travel apps have agreed to pay $35 million and will be prohibited from deceiving consumers about fees to settle the Federal Trade Commission’s allegations that they unfairly charged consumers hidden fees and misrepresented the total prices consumers would pay and the benefits of the companies’ VIP Support and Price Freeze services.

The FTC’s complaint alleges that despite its “no hidden fees” promises, Canadian company Hopper Inc. and its Massachusetts-based subsidiary Hopper (USA) Inc., unfairly charged users without their consent for “Tip” and VIP Support fees that the company claimed were optional yet were hidden and pre-selected for consumers.

The FTC filed a lawsuit against the three largest prescription drug benefit managers (PBMs)—Caremark Rx, Express Scripts (ESI), and OptumRx—and their affiliated group purchasing organizations (GPOs) for engaging in anticompetitive and unfair rebating practices that have artificially inflated the list price of insulin drugs.

On February 4, 2026, the Federal Trade Commission secured a landmark settlement with Express Scripts, Inc., and its affiliated entities (collectively “ESI”). The settlement requires ESI to adopt fundamental changes to its business practices that increase transparency, are expected to drive down patients’ out-of-pocket costs for drugs like insulin by up to $7 billion over 10 years, bring millions of dollars in new revenue to community pharmacies each year, and advance the Trump Administration’s key healthcare priorities.

Amazon will pay $2.25 million in civil penalties to settle FTC allegations that the online retail giant knowingly violated the 609(e) of the Fair Credit Reporting Act by refusing to provide transaction records to consumers whose personal information was used by identity thieves to commit fraud.

The FTC will prohibit data broker Kochava and its subsidiary from selling, sharing or disclosing sensitive location data without consumer consent to settle allegations the companies sold location data from hundreds of millions of mobile devices that could be used to trace the movements of individuals.

The FTC is requiring Aurobindo Pharma Limited to divest four different generic drug products to complete its $250 million acquisition of Lannett Company Inc.